AKT1 and B-cell chronic lymphocytic leukemia: The PI3K/AKT pathway has been shown to play a central role in promoting cell survival and growth of B-cell CLL (Barragán et al, 2002, 2006; Cuní et al, 2004; Petlickovski et al, 2005; Longo et al, 2007).